P. Tak

Rheumatology · 2001–2016

A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom P. Tak trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Feldmann

Who trusts P. Tak overall

  1. Bozena Kaminska
  2. Nikolaos G. Frangogiannis
  3. T. Lawrence
  4. M. Park
  5. Matthew P. Vincenti
  6. E. Colombo
  7. Haitian Lu

Papers from P. Tak's perspective

Ordered by how strongly the researchers P. Tak trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. (New England Journal of Medicine)
  2. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? (Annual Review of Immunology)
  3. IL-17 and Th17 Cells. (Annual Review of Immunology)
  4. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. (New England Journal of Medicine)
  5. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. (The Lancet)
  6. The British Society for Rheumatology Biologics Register (Annals of the Rheumatic Diseases)
  7. NF-κB functions as a tumour promoter in inflammation-associated cancer (Nature)
  8. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. (Arthritis & Rheumatism)
  9. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. (American Journal of Human Genetics)
  10. Lymphoid neogenesis in chronic inflammatory diseases (Nature reviews. Immunology)

Their papers